Assay solution compositions and methods for GPCR arrays

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S007100, C436S501000, C436S518000, C424S009100, C424S164100, C530S300000, C530S350000, C530S356000

Reexamination Certificate

active

07816096

ABSTRACT:
Buffered assay solutions for performing 1) binding or 2) functional assays on GPCR arrays, along with methods for their use are described. The buffered assay solution has an underlying composition having: a buffer reagent with a pH in the range of about 6.5 to about 7.9; an inorganic salt of either a monovalent or divalent species, at a concentration from about 1 mM to about 500 mM; and optionally a combination of: c) a blocker reagent at a concentration of about 0.01 wt. % to about 2 wt. % of the composition, or d) protease-inhibitor at a concentration of about 0.001 mM to about 100 mM. In an embodiment for functional assay uses, the composition is modified to also include a GTP-analogue, a guanosine 5′-diphosphate (GDP) salt, and/or an anti-oxidant reagent.

REFERENCES:
J. Drews, “Drug Discovery: A Historical Perspective”, Mar. 17, 2000, vol. 287, Science, pp. 1960-1964.
P. Ma et al., “Value of Novelty?”, Nature Reviews, Drug Discovery, vol. 1, Aug. 2002, pp. 571-572.
K.L. Pierce et al., “Seven-Transmembrane Receptors”, Nature Reviews, Molecular Cell Biology, vol. 3, Sep. 2002, pp. 639-650.
A.D. Howard et al., “Orphan G-protein-coupled receptors and natural ligand discovery”, TRENDS in Pharmacological Sciences, vol. 22, No. 3, Mar. 2001, pp. 132-140.
I.A. Hemmilä et al., “Novel detection strategies for drug discovery”, DDT, vol. 7, No. 18 (Suppl.), 2002, pp. S150-S156.
J.C. Ventor et al., “The Sequence of the Human Genome”, Science, vol. 291, Feb. 16, 2001, pp. 1304-1351.
A.L. Hopkins et al., “The druggable genome”, Nature Reviews, Drug Discovery, vol. 1, Sep. 2002, pp. 727-730.
S.L. Schreiber, “Target-Oriented and Diversity-Oriented Organic Synthesis in Drug Discovery”, Science, vol. 287, Mar. 17, 2000, pp. 1964-1969.
J. Ziauddin et al., “Microarrays of cells expressing defined cDNAs”, Nature, vol. 411, May 3, 2001, pp. 107-110.
O.E. Beske et al., “High-throughput cell analysis using multiplexed array technologies”, DDT, vol. 7, No. 18 (Suppl.), 2002, pp. S131-S135.
P. Mitchell, “A perspective on protein microairays”, Nature Biotechnology, vol. 20, Mar. 2002, pp. 225-229.
G. MacBcath et al., “Printing Proteins as Microarrays for High-Throughput Function Determination”, Science, vol. 289, Sep. 8, 2000, pp. 1760-1763.
Y. Fang et al., “Membrane Protein Microanays”, J. Am. Chem. Soc., vol. 124, No. 11, 2002, pp. 2394-2395.
Y. Fang et al., “G protein-coupled receptor microanays for drug discovery”, DDT, vol. 8, No. 16, Aug. 2003, pp. 755-761.
Y. Fang et al., “G-protein-coupled Receptor Microarrays”, ChemBioChem, 2002, vol. 3, pp. 987-991.
S.R. George et al., “G-Protein-Coupled Receptor Oligomerization and Its Potential for Drug Discovery”, Nature, vol. 1, Oct. 2002, pp. 808-820.
S.N. Bailey et al., “Applications of transfected cell microanays in high-throughput drug discovery”, DDT, vol. 7, No. 18 (Suppl.), 2002, S113-S135.
H.Y. Erbil et al., “Transformation of a Simple Plastic into a Superhydrophobic Surface”, Science, vol. 299, Feb. 28, 2003, pp. 1377-.
B. Schweitzer et al., “Multiplexed protein profiling on microanays by rolling-circle amplification”, Nature Biotechnology, vol. 20, Apr. 2002, pp. 359-365.
B. Schweitzer et al., “Immunoassays with rolling circle DNA amplification: A versatile platform for ultrascnsitive antigen detection”, Proc. Natl. Acad. Sci., Aug. 29, 2000, vol. 97, No. 18, pp. 10113-10119.
M. Schena et al., “Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray”, Science, vol. 270, Issue 5235, Oct. 20, 1995, pp. 467-470.
Hawes BE and van Biesen T, Current Protocols in Pharmacology, “Protein Tyrosine Kinase Activity Assays”, Unit 3.5, pp. 3.5.1 to 3.5.18.
Boehringer Mannheim Corp., 1998 Biochenicals Catalog, pp. 486-493 (1998).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Assay solution compositions and methods for GPCR arrays does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Assay solution compositions and methods for GPCR arrays, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Assay solution compositions and methods for GPCR arrays will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4205344

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.